ACMG
ACMG, NSGC, and others in the genetics community are monitoring whether the widely used online clinical genetics database could be at risk.
With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are weighing the pros and cons of genetic screening.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
Researchers described the process they took to adapt their methodology for improved BRCA variant classification through ClinGen in a new study this week.
Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
At the American College of Medical Genetics and Genomics annual meeting, NICHD Director Diana Bianchi reported that whole-body MRI was the best follow-up test to confirm or rule out cancer.